MUC1 and non-small cell lung carcinoma: Additionally, in a NSCLC model, the combination of prostate stem cell antigen (PSCA)- and MUC1-targeting CAR-T cells synergistically eliminated PSCA+ and MUC1+ cancer cells [89].